- Home
- OMH vs INMB Comparison
OMH vs INMB Comparison
Compare OMH & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OMH | INMB |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.1M | 34.3M |
| IPO Year | 2022 | 2018 |
Fundamental Metrics
Financial Performance| Metric | OMH | INMB |
|---|---|---|
| Price | $1.07 | $1.23 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | N/A | ★ $5.40 |
| AVG Volume (30 Days) | 18.7K | ★ 360.2K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $50,000.00 |
| Revenue This Year | $28.40 | N/A |
| Revenue Next Year | $23.07 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $0.59 | $1.09 |
| 52 Week High | $4.33 | $11.64 |
Technical Indicators
Market Signals| Indicator | OMH | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 35.51 | 46.18 |
| Support Level | $0.98 | $1.21 |
| Resistance Level | $1.38 | $1.48 |
| Average True Range (ATR) | 0.06 | 0.07 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 0.00 | 54.35 |
Price Performance
Historical ComparisonAbout OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.